Tredaptive

Nicotinic acid and laropiprant modified-release tablets for treating dyslipidaemia, particularly combined mixed dyslipidaemia and primary hypercholesterolaemia.

PHARMACOLOGY

Tredaptive combines nicotinic acid (niacin), a lipid-lowering agent, with laropiprant, a selective antagonist of the prostaglandin D2 receptor subtype 1.1 Laropiprant has no effect on lipid levels, but simply suppresses the flushing caused by nicotinic acid.

CLINICAL STUDIES

In a 24-week trial in 1,216 patients, nicotinic acid (1g/day for four weeks, followed by 2g/day for 20 weeks) given in combination with laropiprant significantly improved lipid profiles compared with placebo and caused markedly less flushing than the same dose of nicotinic acid alone.2

In another trial, the 726 patients randomised to receive nicotinic acid (1g/day for four weeks, followed by 2g/day for 12 weeks) given in combination with laropiprant experienced significantly fewer days of flushing per week during the 16-week treatment period than the 729 patients who were randomised to receive nicotinic acid alone (0.5g/day for four weeks gradually titrated to 2g/day for the final four weeks), despite more rapid nicotinic acid titration.3

View Tredaptive drug record

REFERENCES

  1. Tredaptive Summary of Product Characteristics. July 2008.
  2. Maccubbin D, Bays H et al. Lipid-modifying efficacy and tolerability of e-r niacin/laropiprant in patients with primary hypercholesterolaemia or mixed dyslipidaemia. Int J Clin Pract 2008: 62; 1959-70.
  3. Maccubbin D, Koren M et al. Flushing profile of e-r niacin/laropiprant versus gradually titrated niacin e-r in patients with dyslipidemia with and without ischemic cardiovascular disease. Am J Cardiol 2009: 104; 74-81.

Further information: MSD

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Drug shortages - live tracker

Drug shortages - live tracker

Added: fludroxycortide, levofloxacin, Noriday, Ongentys...

Vaping still safer than smoking, say health bosses after report of severe lung injury
Free online vestibular rehabilitation tool 'highly effective' for vertigo symptoms

Free online vestibular rehabilitation tool 'highly effective' for vertigo symptoms

GPs should consider online vestibular rehabilitation...

Thiazides better than ACE inhibitors as first-line antihypertensives, large-scale analysis suggests